Read More Healthcare Industry News Aethlon Medical, Inc. (NASDAQ: AEMD) flags accelerating clinical enrollment as Hemopurifier strategy tightens Find out how Aethlon Medical’s faster clinical enrollment reshapes execution risk, investor sentiment, and the future of the Hemopurifier platform. byPallavi MadhirajuFebruary 15, 2026